Q1 2020 Capricor Therapeutics Inc Earnings Call Transcript
Greetings, and welcome to the Capricor Therapeutics, Inc. first quarter 2020 earnings conference call. During the presentation, all participants will be in a listen-only mode. (Operator Instructions). As a reminder, this conference is being recorded Thursday, May 14, 2020. I'd now like to turn the conference over to AJ Bergmann, Capricor CFO. Please go ahead.
Thank you, and good afternoon, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates; our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies; our plan plans to present or report additional data; our plans regarding regulatory filings; potential regulatory developments regarding our product candidates; and our possible uses of existing cash and investment resource.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |